Certified by Founder Lodge
UCB Ventures
Belgium - Brussels
INVESTOR
1 Disclosed Funding Rounds $52,000,000
2 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
UCB Ventures is the strategic corporate venture fund of UCB Pharma.
Our mission is to further strengthen UCB's ability to create value from novel insights and technologies that can transform
| Company | Date | Round | Raised |
|---|---|---|---|
 Switch Therapeutics |
March, 15 ,2023 | Series A | $52,000,000 |
 Vianautis |
November, 14 ,2023 | Series A | $25,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
